Outcomes of Rapid Deployment Aortic Valve Replacement: Early Experience in Wellington Hospital

Rapid deployment (RD) aortic valve replacement (AVR) using the Edwards Intuity Elite Valve System is a significant breakthrough in advancement comparison with other current conventional sutured surgical AVR. This study aimed to analyse early experiences this novel bioprosthesis. 60-month prospective study, between July 2017 and 2022, found that 59 patients had RD bioprosthesis implanted at institution. Median follow-up period was 12 months. Baseline preoperative characteristics, isolated or concomitant procedures, prosthesis-related events, survival rates, haemodynamics were evaluated. Primary endpoints pacemaker implantation (PPM) neurological paravalvular leaks, 30-day mortality rates. Secondary reintervention, degeneration, arrhythmia, hospital stay, readmission Approximately 64% males, mean age of 75±3 years. Isolated AVR performed 54% rest procedures. Cardiopulmonary bypass cross-clamping times acceptable. In group, PPM rates 5%, 1.7% experiencing minor stroke event. One patient leak, which moderate haemodynamics. Mean gradient discharge 11±3 mmHg. There no inpatient post-discharge zero. Re-operation degeneration promising excellent results small cohort patients, validating for more usage rapid suitable patients.